Delivery Order SPE2DR25D1205-SPE2DR26F1AD4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,092.55 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 30 mg tablets in unit dose packaging (10-count units). This firm fixed price contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Tolvaptan 30 mg tablets in unit-dose packaging of 10 units, with a ceiling value of $18,283.30. The award, issued on October 24, 2025, utilizes firm fixed-price pricing with an ultimate completion date of October 27, 2025. This is a non-set-aside competitive award with performance at AmerisourceBergen's Conshohocken, Pennsylvania location, and the delivery order is structured as a child contract...
- The Defense Logistics Agency awarded a $70,470.28 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packages of 10. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award selection. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of December 16, 2025. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Tolvaptan 30 mg tablets in unit dose packaging of 10s. This contract is a non-set-aside, competitively awarded delivery order with firm fixed pricing, valued at $48,454.20, with a completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Tolvaptan 15 mg tablets in unit-dose packaging of 10 units. This competitive award, valued at $44,199.07 on a firm fixed-price basis, is scheduled for completion by November 17, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packaging (10-count). The contract carries a ceiling value of $181,808 under a firm fixed-price arrangement with a completion date of July 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tolvaptan 15 mg tablets in unit dose packaging on September 9, 2025. This competitively awarded, non-set-aside contract is valued at $15,578.98 and requires completion by September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, under a firm fixed-price arrangement typical of delivery orders against existing...
- The Defense Logistics Agency awarded a delivery order valued at $15,233.64 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 15 mg tablets in unit dose packaging of 10s. This non-set-aside contract was competitively awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed price pricing and represents a child delivery order issued under a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,084.10 by the Defense Logistics Agency's Medical Supply Chain on September 9, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packaging of 10 units. This competitively awarded, firm fixed-price contract is not set aside for any particular business category and is scheduled for completion by September 10, 2025. The contract falls under a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,444.55 firm fixed price contract is for the delivery of 10-count units of the 30 mg Tolvaptan tablet medication. The delivery order has a completion date of May 22, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1AD4Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,880 delivery order to AmerisourceBergen Drug Corp for Tolvaptan 30 mg tablets in unit dose packaging on January 16, 2026, with an ultimate completion date of January 20, 2026. This non-set-aside contract was competitively awarded on a firm fixed-price basis to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major healthcare solutions provider specializing in pharmaceutical distribution to federal agencies. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The contract enables the company to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/15/26 |